Topical thymopentin therapy in HIV positive patients with recurrent oral candidiasis: A pilot study

New Microbiologica

Volumn 19, Issue 4, 1996, Pages 351-356

  Coppola, S ^a   Buccoliero, G ^a   Laddago, V ^a   Monno, L ^a   Perrone, A ^a   Guida, G ^a   Schiraldi, O ^a   Angarano, G ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

AIDS; Oral candidiasis; Secretory IgA; Thymopentin

Indexed keywords

IMMUNOLOGICAL ADJUVANT; SECRETORY IMMUNOGLOBULIN; THYMOPENTIN;

AIDS RELATED COMPLEX; ARTICLE; CANDIDA ALBICANS; CHEMISTRY; CLINICAL TRIAL; DRUG EFFECT; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LEUKOCYTE COUNT; PILOT STUDY; SALIVA; THRUSH;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INHALATION; AIDS-RELATED OPPORTUNISTIC INFECTIONS; CANDIDA ALBICANS; CANDIDIASIS, ORAL; HUMANS; IMMUNOGLOBULIN A, SECRETORY; LEUKOCYTE COUNT; PILOT PROJECTS; SALIVA; THYMOPENTIN;

EID: 0030253216     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. ALLEN, R.C., STJERNHOLM, R.L., and STEELE, R.M. (1972). Evidence for the generation of an electronic exicitation state(s) in human polymorphonuclear leukocytes and its participation in bactericidal activity. Biochemical and Biophysical Research Communications, 47, 679-684.
2. CLUMECK, N., CRAN, S., VAN DE PERRE, P., MASCART-LEMONE, F., DUCHATEAU, J., and BOLLA, K. (1985). Thymopentin treatment in AIDS and pre-AIDS patients. Survey of Immunological Research, 4 (suppl. 1), 58-62.
3. DE WIT, S., WEERTS, D., GOOSENS, H., and CLUMECK, N. (1989). Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS. Lancet i, 746-747.
4. EPSTEIN, J.B., KIMURA, L.H., MENARD, T.W., TRUELOVE, E.L., and PEARSALL, N.N. (1982). Effects of specific antibodies on the interaction between the fungus Candida albicans and human oral mucosa. Archives Oral Biology, 27, 469-474.
5. GOLDSTEIN, G., SHEID, M.P., BOYSE, E.A., SCHENGER, D.H., and VAN WAUWE, J.A. (1979). Synthetic pentapeptide with biological activity characteristic of the thymic hormone thymopentin. Science, 204, 1309-1310.
6. HERMANS, P., and CLUMECK, N. (1989). Preliminary results on clinical and immunological effects of thymus hormone preparation in AIDS. Medical Oncology & Tumor Pharmacotherapy, 6 (1), 55-58.
7. KALO-KLEIN, A., and WITKIN, S.S. (1990). Prostaglandin E2 enhances and gamma interferon inhibits germ tube formation in Candida albicans. Infection and Immunity, 58, 260-262.
8. KORTING, H.C., OLLERT, M., GEORGI, A., and FROSCHL, M. (1988). In vitro susceptibilities and biotypes of Candida albicans isolated from the oral cavities of patients infected with Human Immunodeficiency Virus. Journal of Clinical Microbiology, 26 (12), 2626-2631.
9. LATORRE, A., ROMAGNO, D., PALUMBO, A., and DAMMACCO, F. (1987). Effetti della Timopentina e dell'interferone a-2A ricombinante sulla biochemiluminescenza dei granulociti neutrofili in soggetti con infezione da virus HIV. Giornale Clinica Medica LXVIII, 67, 351-355.
10. MASCART-LEMONE, F., HUYGEN, K., CLUMECK, N., BRENEZ, D., BOLLA, K., and DUCHATEAU, J. (1983). Stimulation of cellular function by thymopentin (TP-5) in three AIDS patients. Lancet, 2, 735-736.
11. MCNABB, P., and TOMASI, T.B. (1981). Host defence mechanism at mucosal surfaces. Annual Review of Microbiology, 35, 477-496.
12. MOSMANN, T.R., CHERWINSKI, H., BOND, M.W., GIEDLIN, M.A., and COFFMAN, R.L. (1986). Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. Journal of Immunology, 136, 2348-2357.
13. NG, T.T.C., and DENNING, D.W. (1993). Fluconazole resistance in Candida in patients with AIDS-therapeutic approach. Journal of Infection, 26, 117-125.
14. SCOTT, P., and KAUFMANN, S.H.E. (1991). The role of T-cell subsets and cytokines in the regulation of infection. Immunology Today, 12, 346-348.
15. SILVESTRIS, F., GERNONE, A., FRASSINO, M.A., and DAMMACCO, F. (1989). Immunologic effects of long-term thymopentin treatment in patients with HIV-induced lymphadenopathy syndrome. Journal of Laboratory Clinical Medicine, 113 (2), 139-144.
16. SOBEL, J.D. (1990). Controversial aspect of candidiasis in the acquired immunodeficiences syndrome. In: Vanden Bossche H., MacKenzie D.W.R. Eds, Mycoses in AIDS patients. Plenum Press. New York (USA).
17. VUDHICHAMNONG, K., WALKER, D.M., and RULEY, H.C. (1982). The effect of secretory immunoglobulin A on the in vitro adherence of the yeast Candida albicans to human oral epithelial cells. Archives of Oral Biology, 27, 617-621.
18. WARNOCK, D.W. (1990). Immunological aspects of candidosis in Aids patients. In: Vanden Bossche H., MacKenzie, D.W.R. Eds, Mycoses in AIDS patients. Plenum Press. New York (USA).